Incretin hormones and insulin secretion

Hormone and Metabolic Research

Volumn 36, Issue 11-12, 2004, Pages 733-734

  Ahrén, Bo ^a   Gromada, Jesper ^b   Schmitz, Ole ^c  

^a LUND UNIVERSITY   (Sweden)

^b Lilly Research Laboratories   (Germany)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GASTRIN; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HORMONE INHIBITOR; HORMONE RECEPTOR STIMULATING AGENT; INCRETIN; INSULIN; UNCLASSIFIED DRUG;

CARBOHYDRATE INTAKE; EDITORIAL; HORMONE ACTION; HUMAN; INSULIN RELEASE; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

DIABETES MELLITUS; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS;

EID: 12244285688     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-826153     Document Type: Editorial

References (12)

1. Bayliss WM, Starling EH. The mechanism of pancreatic secretion. J Physiol 1902; 28: 325-353
2. Edkins JS. The chemical mechanism of gastric secretion. J Physiol 1906; 34: 133-144
3. Zunz E, La Barre J. Contributions à l'étude des variations physiologiques de la secretion interne du pancreas: relations entre les secretions externe et intene du pancreas. Arch Int Physiol Biochim 1929; 31: 20-44
4. Creutzfeldt W. The incretin concept today. Diabetologia 1979; 16: 75-85
5. Holst JJ, Ørskov C. Incretin hormones - an update. Scand J Clin Lab Invest 2001; 234 (1): 75-85
6. Moore B, Edie ES, Abram JH. On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane. Biochem J 1906; 1: 28-38
7. Ahrén B, Holst JJ, Efendic S. Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes. J Clin Endocrinol Metab 2000; 85: 1043-1048
8. Gutniak M, Ørskov C, Holst J, Ahrén B, Efendic S. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med 1992; 326: 1316-1322
9. Nathan DM, Schreiber E, Fogel H, Mojsov S, Habener JF. Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects. Diabetes Care 1992; 15: 270-276
10. McIntyre N, Holdsworth CD, Turner DS. New interpretation of oral glucose tolerance. Lancet 1964; 2: 20-21
11. Yamada Y, Seino Y. Physiology of GIP - lessons from GIP receptor KO mice. Horm Metab Res 2004; 36: 771-774
12. Stoffers DA. The development of β cell mass: recent progress and potential role of GLP-1. Horm Metab Res 2004; 36: 811-821